Effect of thrombelastography on timing of coronary artery bypass grafting

Zhiyuan Yang1, Zhouliang Xie1, Xueliang Pei1

  • 1Department of Cardiovascular Surgery, Henan Provincial People's Hospital, Zhengzhou, Henan 450003, P.R. China.

Insights

Thrombelastography (TEG) guides surgical timing for coronary artery bypass grafting (CABG) patients on dual antiplatelet therapy (DAPT). This approach reduces waiting times and bleeding, improving patient outcomes.

Area of Science:

  • Cardiology
  • Hematology
  • Surgical Innovation

Background:

  • Patients with acute coronary syndrome (ACS) undergoing coronary artery bypass grafting (CABG) often receive dual antiplatelet therapy (DAPT).
  • Determining optimal surgical timing after DAPT cessation is critical to balance bleeding risk and ischemic events.
  • Current practices for surgical timing may lead to prolonged waiting periods.

Purpose of the Study:

  • To investigate the guiding value of thrombelastography (TEG) in selecting surgical timing for patients scheduled for CABG.
  • To compare outcomes between patients managed with TEG-guided timing and standard timing protocols.

Main Methods:

  • A randomized controlled trial involving 90 ACS patients scheduled for CABG receiving DAPT.
  • Patients were allocated to a TEG group (n=45) or a non-TEG (control) group (n=45).
  • TEG analysis guided surgical timing in the TEG group based on adenosine diphosphate (ADP) induced platelet function (MAADP), while the control group followed standard 5-7 day withdrawal.

Main Results:

  • The TEG group experienced a significantly shorter median hospital stay (P=0.037).
  • The TEG group had significantly lower bleeding amounts (220.16±80.56 ml vs 435.29±90.16 ml, P=0.032).
  • While not statistically significant (P=0.23), red blood cell transfusions differed between groups.

Conclusions:

  • Thrombelastography (TEG) provides a valuable tool for guiding surgical timing in CABG patients on DAPT.
  • TEG-guided timing can potentially reduce perioperative bleeding and hospital stay.
  • This approach allows for more appropriate and potentially expedited surgical intervention.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
492
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
283
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
391
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
703
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.3K